Search Results - "Aznar MA"

A comparative computational analysis of IFN-alpha pharmacokinetics and its induced cellular response in mice and humans.

Authors: Kalra, Priyata Kister, Bastian Fendt, Rebekka et al.

Source: PLoS Computational Biology. 9/25/2025, Vol. 21 Issue 9, p1-18. 18p.

Personalised Rational Drug Monitoring Combined with KABP Model Health Education to Improve Adherence and Prognosis of CAR-T Cell Therapy.

Authors: Yang, Guimei Li, Lihong Li, Yanchun et al.

Source: Patient Preference & Adherence. Dec2025, Vol. 19, p4131-4140. 10p.

Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver.

Authors: Yang, Jeffrey Morhard, Robert Huth, Hannah et al.

Source: PLoS ONE. 4/22/2026, Vol. 21 Issue 4, p1-15. 15p.

Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer.

Authors: Han, Jung Ho Lee, Eun-Ji Park, Young-Hoon et al.

Source: Oncogenesis. 3/18/2026, Vol. 15 Issue 1, p1-13. 13p.

Virtual rehabilitation for patients with osteoporosis or other musculoskeletal disorders: a systematic review.

Authors: Thuilier, Eléa Carey, John Dempsey, Mary et al.

Source: Virtual Reality; Jun2024, Vol. 28 Issue 2, p1-33, 33p

Top 100 Most Cited Publications on CTLA-4 Molecule in Cancer Research: A Bibliometric Analysis.

Authors: El Idrissi, Hossam Hilal Balar, Ibtissam

Source: Middle East Journal of Cancer. Jan2023, Vol. 14 Issue 1, p1-16. 16p.

SIRPA, BTN3A1, and TDO2 in osteosarcoma: a prognostic triad with therapeutic implications from integrated genomic and pharmacogenomic data.

Authors: Zhang, Han-jing Yang, Zhi-Jun Huang, Wen et al.

Source: Journal of Orthopaedic Surgery & Research. 8/7/2025, Vol. 20 Issue 1, p1-17. 17p.

Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.

Authors: Chang, Yung-Chieh Chen, Szu-Jung Chen, Shang-Hung et al.

Source: Journal of Biomedical Science. 7/24/2025, Vol. 32 Issue 1, p1-22. 22p.

(CAR-)T cell dynamics following chimeric antigen receptor T cells for large B cell lymphoma: a translational tale.

Authors: Gambella, M. Carlomagno, S. Raiola, A. M. et al.

Source: Leukemia & Lymphoma. Jun2025, Vol. 66 Issue 6, p1036-1044. 9p.

MUC18-Directed chimeric antigen receptor T cells for the treatment of mucosal melanoma.

Authors: Zhang, Fenghao Du, Haizhen Liu, Kaiping et al.

Source: Journal of Translational Medicine. 4/24/2025, Vol. 23 Issue 1, p1-14. 14p.

Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment.

Authors: Wu, Xinhong Yuan, Feng Guo, Liantao et al.

Source: BMC Cancer. 2/18/2025, Vol. 25 Issue 1, p1-15. 15p.

In vivo CAR-cell therapy: current challenges and emerging therapeutic advances.

Authors: Yang YM Bao B Cao YH et al.

Source: Molecular biomedicine [Mol Biomed] 2026 Apr 20; Vol. 7 (1). Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

Innovative gene engineering and drug delivery systems for dendritic cells in cancer immunotherapy.

Authors: Prakash, Mridula Cortez, Cedric David Jayaraman, Akshaya et al.

Source: Journal of Biomedical Science. 11/1/2025, Vol. 32 Issue 1, p1-44. 44p.

Multicultural data assistance mining analysis for ideological and political education in smart education platforms using artificial intelligence.

Authors: Li, Hanjia¹, 814273325@qq.com

Source: Wireless Networks (10220038); Jan2025, Vol. 31 Issue 1, p567-581, 15p

Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.

Authors: Hu, Yun Paris, Sébastien Sahoo, Narayan et al.

Source: Journal of Nanobiotechnology. 10/1/2024, Vol. 22 Issue 1, p1-22. 22p.

Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia.

Authors: Mei, Yihan Liu, Yu Liu, Wenbing et al.

Source: Experimental Hematology & Oncology. 9/6/2024, Vol. 13 Issue 1, p1-15. 15p.

Advanced Mucosal Melanoma Therapies: Current Status and Future Directions.

Authors: Zhang Y Zhao D Wu D

Source: Current treatment options in oncology [Curr Treat Options Oncol] 2026 Apr 07; Vol. 27 (1). Date of Electronic Publication: 2026 Apr 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

Molecular subtypes in pancreatic cancer: from academic promise to clinical reality.

Authors: D'Empaire Altimari DM Bevere M Espinet E et al.

Source: Molecular cancer [Mol Cancer] 2026 Mar 09; Vol. 25 (1). Date of Electronic Publication: 2026 Mar 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

Authors: Vo, Manh-Cuong Tran, Van-Dinh-Huan Nguyen, Van-Tan et al.

Source: Journal of Hematology & Oncology. 10/27/2025, Vol. 18 Issue 1, p1-31. 31p.

Breast neoplasm epithelial-mesenchymal transition and cytokines: a systematic review.

Authors: Chen, Yian Ding, Haining Song, Jiaqing et al.

Source: Cancer Cell International. 9/29/2025, Vol. 25 Issue 1, p1-31. 31p.